Long-term Outcomes of Patients with Rheumatoid Arthritis in Remission
ConditionRheumatoid Arthritis (RA)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDiakonhjemmet Hospital
About this trial
The goal of this multi-center prospective observational study is to develop knowledge on how to best personalize treatment and follow-up strategies for patients with RA in remission, with the intention to prevent relapse of disease activity and progression of joint damage and at the same time avoid the use of unnecessary treatment and health resources.
The investigators will perform an extensive evaluation of all patients who participated in the ARCTIC REWIND study 10 and 15 years after they achieved sustained remission and received different treatment strategies.
Eligibility criteria
Qualifiers
Participation in the ARCTIC REWIND trial
Patients able and willing to give written informed consent and comply with the requirements of the study protocol
Disqualifiers
Psychiatric or mental disorders, alcohol abuse, other substance abuse, other factors making adherence to the study protocol impossible.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Diakonhjemmet Hospital
Lead sponsor
South-Eastern Norway Regional Health Authority
Collaborator
The Research Council of Norway
Collaborator
Olav Thon Foundation
Collaborator
Source ClinicalTrials.gov